0001140361-24-032293.txt : 20240702
0001140361-24-032293.hdr.sgml : 20240702
20240702215320
ACCESSION NUMBER: 0001140361-24-032293
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240628
FILED AS OF DATE: 20240702
DATE AS OF CHANGE: 20240702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Venkatesan Jay
CENTRAL INDEX KEY: 0001413350
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39990
FILM NUMBER: 241098125
MAIL ADDRESS:
STREET 1: C/O AYER CAPITAL MANAGEMENT, LP
STREET 2: 230 CALIFORNIA ST, SUITE 600
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elicio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001601485
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 113430072
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 451 D STREET, 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: (857) 209-0050
MAIL ADDRESS:
STREET 1: 451 D STREET, 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Angion Biomedica Corp.
DATE OF NAME CHANGE: 20140228
4
1
form4.xml
FORM 4
X0508
4
2024-06-28
0001601485
Elicio Therapeutics, Inc.
ELTX
0001413350
Venkatesan Jay
C/O ELICIO THERAPEUTICS, INC.
451 D STREET, 5TH FLOOR, SUITE 501
BOSTON
MA
02210
true
false
Common Warrants
5
2024-06-28
4
P
0
50000
0
A
Common Stock
50000
50000
D
Pre-Funded Warrants
0.01
2024-06-28
4
P
0
50000
4.99
A
Common Stock
50000
50000
D
Common Warrants
5
2024-06-28
4
P
0
50000
0
A
Common Stock
50000
50000
I
See footnote
Pre-Funded Warrants
0.01
2024-06-28
4
P
0
50000
4.99
A
Common Stock
50000
50000
I
See footnote
Common Warrants
5
2024-06-28
4
P
0
50000
0
A
Common Stock
50000
50000
I
See footnote
Pre-Funded Warrants
0.01
2024-06-28
4
P
0
50000
4.99
A
Common Stock
50000
50000
I
See footnote
Common Warrants
5
2024-06-28
4
P
0
50000
0
A
Common Stock
50000
50000
I
See footnote
Pre-Funded Warrants
0.01
2024-06-28
4
P
0
50000
4.99
A
Common Stock
50000
50000
I
See footnote
Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%.
The Common Warrants expire on July 1, 2029.
Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%.
The Pre-Funded Warrants do not have an expiration date.
The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any.
/s/ Jay Venkatesan
2024-07-02